Australia markets open in 5 hours 12 minutes

Aier Eye Hospital Group Co., Ltd. (300015.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
12.08+0.10 (+0.83%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 111.75B
Enterprise value 108.74B
Trailing P/E 32.73
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.71
Price/book (mrq)5.97
Enterprise value/revenue 5.69
Enterprise value/EBITDA 23.62

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-46.57%
S&P500 52-week change 323.06%
52-week high 323.27
52-week low 311.80
50-day moving average 313.52
200-day moving average 316.37

Share statistics

Avg vol (3-month) 377.05M
Avg vol (10-day) 369.8M
Shares outstanding 59.33B
Implied shares outstanding 69.33B
Float 84.23B
% held by insiders 155.73%
% held by institutions 118.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.1
Forward annual dividend yield 40.83%
Trailing annual dividend rate 30.08
Trailing annual dividend yield 30.64%
5-year average dividend yield 40.37
Payout ratio 427.33%
Dividend date 3N/A
Ex-dividend date 408 June 2023
Last split factor 21.300045:1
Last split date 308 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 17.53%
Operating margin (ttm)31.21%

Management effectiveness

Return on assets (ttm)10.46%
Return on equity (ttm)19.67%

Income statement

Revenue (ttm)19.11B
Revenue per share (ttm)2.10
Quarterly revenue growth (yoy)17.20%
Gross profit (ttm)N/A
EBITDA 5.44B
Net income avi to common (ttm)3.35B
Diluted EPS (ttm)0.37
Quarterly earnings growth (yoy)37.80%

Balance sheet

Total cash (mrq)7.61B
Total cash per share (mrq)0.82
Total debt (mrq)4.59B
Total debt/equity (mrq)23.17%
Current ratio (mrq)1.71
Book value per share (mrq)2.01

Cash flow statement

Operating cash flow (ttm)6.06B
Levered free cash flow (ttm)2.94B